RxDoctor Payments Data

Gyan Pareek, MD

Urology · Providence, RINPI 1376654350

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $65,480 of the $82,763 with a category attached, or 79.1%. 26 manufacturers reported payments, led by Boston Scientific at 58.0% of the total. Reporting peaked in 2023 at $25,960 and has fallen 68.7% since, to $8,114 in 2025. Among urology clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,763in general payments, 2019–2025

Across 141 payments — averaging $586.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$48K
  • Gyrus ACMI, Inc.$9K
  • Ambu A/s$8K
  • Cook Incorporated$7K
  • Northgate Technologies, Inc.$4K
  • Photocure Inc$3K
  • plus $4K from 20 others

What the payments were for

  • Consulting fees$65,48079%
  • Speaking & faculty fees$12,30415%
  • Travel & lodging$1,8662%
  • Food & beverage$3,0134%
  • Education$1000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,763 in reported general payments places this provider in the 95th percentile of 55 urology providers in Rhode Island.

See all urology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$154,630
Medicare patients
521
Services billed
2,877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Thiola EcTiopronin11$87,468
Potassium Citrate ErPotassium Citrate88$10,606
Tamsulosin Hcl610$9,564
Finasteride449$6,717
Methenamine Hippurate22$1,855
Oxybutynin Chloride ErOxybutynin Chloride34$969
Alfuzosin Hcl ErAlfuzosin Hcl47$967
Dutasteride38$713
Trospium Chloride11$705
Oxybutynin Chloride30$617
Allopurinol39$466
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$329
Doxazosin Mesylate12$210
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim46$160
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$124

Paid to pharmacies, not to this prescriber.

Other urology in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →